Clinical Trial Update: A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating enzastaurin in combination with chemotherapy versus placebo with chemotherapy for prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzastaurin (enzastaurin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-11-06